Literature DB >> 28448254

TAFRO syndrome or Castleman-Kojima syndrome: a variant of multicentric Castleman disease.

Jennifer M Hawkins1, Vinodh Pillai1.   

Abstract

Entities:  

Year:  2015        PMID： 28448254     DOI： 10.1182/blood-2015-07-662122

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  TAFRO syndrome: A case report and review of the literature.

Authors:  Tieying Hou; Jaspreet Dhillon; Wenbin Xiao; Elaine S Jaffe; Amy M Sands; Vishala Neppalli; George Deeb; Nan Zhang
Journal:  Hum Pathol (N Y)       Date:  2017-04-21

2.  Clinical and Molecular Characteristics of 60 Patients With Human Immunodeficiency Virus-Negative Castleman Disease.

Authors:  Siyu Qian; Mengjie Ding; Huting Hou; Zeyuan Wang; Jieming Zhang; Yue Zhang; Meng Dong; Linan Zhu; Guannan Wang; Wencai Li; Xudong Zhang
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

3.  DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cells.

Authors:  Jung-Yeon Lim; Sascha H Duttke; Turner S Baker; Jihye Lee; Kristyne J Gambino; Nicholas J Venturini; Jessica Sook Yuin Ho; Simin Zheng; Yesai S Fstkchyan; Vinodh Pillai; David C Fajgenbaum; Ivan Marazzi; Christopher Benner; Minji Byun
Journal:  J Exp Med       Date:  2021-05-10       Impact factor: 17.579

4.  International definition of iMCD-TAFRO: future perspectives.

Authors:  Yoshito Nishimura; Midori Filiz Nishimura; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-04-27

5.  Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data.

Authors:  Deanna E Morra; Sheila K Pierson; Dustin Shilling; Sepideh Nemat; Carlos Appiani; Mary Guilfoyle; Craig Tendler; Frits van Rhee; David C Fajgenbaum
Journal:  Br J Haematol       Date:  2018-09-11       Impact factor: 8.615

6.  Analysis of Clinical Characteristics, Pathological Changes and Changes of Interleukin-6 (IL-6) and C-Reactive Protein (CRP) in Children with Castleman's Disease.

Authors:  Chao Hu; Yan Zou; Jing Pan; Jiliang Yang; Tianyou Yang; Tianbao Tan; Jiahao Li
Journal:  Med Sci Monit       Date:  2020-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.